Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil for cognitive dysfunction in children with Down Syndrome
NCT00570128Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Nov 2007
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of donepezil in Down syndrome, sponsored by Eisai Co., Ltd.. Started Nov 2007; status: completed.
02
Drugs
donepezil
03
Conditions
Down syndrome
Beyond the preview
Go deeper on NCT00570128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00570128.